Clinical efficacy and safety of Flebogammadif®, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura
2009 ◽
Vol 19
(5)
◽
pp. 260-268
◽
2006 ◽
Vol 33
(6)
◽
pp. 509-514
◽
1983 ◽
Vol 47
(2)
◽
pp. 69-75
◽
2021 ◽
Vol Publish Ahead of Print
◽
2010 ◽
Vol 10
(3)
◽
pp. E26
◽
1997 ◽
Vol 56
(3)
◽
pp. 191-192
◽
1984 ◽
Vol 48
(6)
◽
pp. 369-376
◽
2009 ◽
Vol 82
(6)
◽
pp. 488-489
◽